EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Healthcare utilisation and cost among individuals with Long COVID in England and Wales: potential value of specialised post-COVID services

Ashkan Dashtban, Mehrdad Mizani iD, Yi Mu, Mamas Mamas, Evan Kontopantelis, Spiros Denaxas, Qi Huang, Kamlesh Khunti, Melissa Heightman, Rouven Priedon, Manuel Gomes, Amitava Banerjee iD

Journal of the Royal Society of Medicine · 2026

DOI: 10.1177/01410768261476537 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Royal Society of Medicine, 2026. Verfasst von Ashkan Dashtban und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health Informatics, University College London, London, UK. Hauptthemen laut MEDLINE: COVID-19, Patient Acceptance of Health Care, Health Care Costs. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Programme Grants for Applied Research, British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare healthcare utilisation and costs for Long COVID (LC) in England and Wales.

Design

Case–control cohort analysis with multiple age-, sex-, ethnicity-, deprivation-, region- and comorbidity-matched control groups: (1) COVID-only, no LC; (2) pre-pandemic; (3) contemporary non-COVID and (4) pre-LC (self-controlled, pre-COVID pandemic).

Setting

National, population-based, linked UK electronic health records (British Heart Foundation/NHS England Secure Data Environment).

Participants

Adults aged ⩾18 years with LC between January 2020 and December 2023. Main outcome measures: Healthcare utilisation (number of consultations/visits per person): primary care (general practitioner (GP)), secondary care (outpatient, inpatient and emergency department, investigations and procedures) and inflation-adjusted cost (£) for LC and control populations.

Results

In England ( n = 295,180) and Wales ( n = 7925), LC was associated with higher utilisation and costs across primary and secondary care. Mean annual total cost for LC versus contemporary controls was £6681.6 versus £2039.9 in Wales (3.27-fold) and £3378.3 versus £1355.8 in England (2.49-fold). GP consultations averaged 26.76 (SD 22.07) per person-year in the Welsh LC cohort versus 14.63 (SD 14.34) in England (absolute difference 12.13 visits/year). Cross-national multiplicative difference-in-differences estimates indicated a 25% greater relative LC-related cost increase in Wales compared with England (ratio 1.25, 95% CI 1.09–1.42), corresponding to an absolute excess of £2501 per person-year (95% CI £1707–£3270).

Conclusions

LC is associated with sustained increases in healthcare utilisation and costs in England and Wales. Our findings suggest that system-level service design may influence healthcare use and costs following COVID-19, warranting further evaluation of post-viral care models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Patient Acceptance of Health CareHealth Care CostsHumansWalesEnglandFemaleMiddle AgedPost-Acute COVID-19 SyndromeMaleAgedAdultCase-Control StudiesSARS-CoV-2Primary Health CareSecondary Health Care

Stichwörter der Autor:innen

Epidemiologic studiesepidemiologyhealth economicshealth policyhealth service research

Autor:innen und Institutionen

  • Institute of Health Informatics, University College London, London, UK.
  • British Heart Foundation Data Science Centre, Health Data Research UK, London, UK.
  • Keele Cardiovascular Research Group, Centre for Prognosis Research, Keele University, Keele, UK.
  • Centre for Primary Care and Health Services Research, University of Manchester, Manchester, UK.
  • Leicester Diabetes Centre, University of Leicester, Leicester, UK.
  • Department of Respiratory Medicine, University College London Hospitals NHS Trust, London, UK.

ORCID-Profile: Mehrdad Mizani, Amitava Banerjee

Förderung

  • Programme Grants for Applied Research
  • British Heart Foundation

Zitieren

APA

Dashtban, A., Mizani, M., Mu, Y., Mamas, M., Kontopantelis, E., Denaxas, S., Huang, Q., Khunti, K., Heightman, M., Priedon, R., Gomes, M., & Banerjee, A. (2026). Healthcare utilisation and cost among individuals with Long COVID in England and Wales: potential value of specialised post-COVID services. Journal of the Royal Society of Medicine. https://doi.org/10.1177/01410768261476537

Vancouver

Dashtban A, Mizani M, Mu Y, Mamas M, Kontopantelis E, Denaxas S, et al. Healthcare utilisation and cost among individuals with Long COVID in England and Wales: potential value of specialised post-COVID services. Journal of the Royal Society of Medicine. 2026. doi:10.1177/01410768261476537

BibTeX
@article{Dashtban2026,
  author = {Dashtban, Ashkan and Mizani, Mehrdad and Mu, Yi and Mamas, Mamas and Kontopantelis, Evan and Denaxas, Spiros and Huang, Qi and Khunti, Kamlesh and Heightman, Melissa and Priedon, Rouven and Gomes, Manuel and Banerjee, Amitava},
  title = {Healthcare utilisation and cost among individuals with Long COVID in England and Wales: potential value of specialised post-COVID services},
  journal = {Journal of the Royal Society of Medicine},
  year = {2026},
  doi = {10.1177/01410768261476537}
}
Kostenlos starten →